|
| |
Image Results
Loading...
Loading...
Preparation Of Lymphocytes From Companies Pages on BioPortfolio:
|
BioPortfolio - Lymphocytes - InDepth
28 Oct 2009 ... View the current Lymphocytes InDepth page on BioPortfolio.com (PDF) .... Companies Developing N. Business Wire via Yahoo! ...
http://www.bioportfolio.com/indepth/Lymphocytes.pdf...
|
BioPortfolio - Generex - GENEREX REPORTS ON NOVEL MECHANISM FOR ...
Killer T lymphocytes eliminate tumors or virally infected cells, and helper T lymphocytes help to activate killer T lymphocytes. Many companies have ...
http://www.bioportfolio.com/news/GENEREX_REPORTS_ON_NOVEL_ME...
|
Blocking the CXCL10:CXCR3 axis for the treatment of COPD
In particular, CXCR3 is highly expressed on CD8+ Tc1 type T lymphocytes. ... emerging industry and the securities of the companies mentioned in this report
...
http://www.bioportfolio.com/LeadDiscovery/PubMed-010402.html...
|
Competitor Analysis: Sphingosine-1-Phosphate (S1P)
These include antibody generation by B lymphocytes, first line immunological ... In addition, the report lists company-specific S1P R&D pipelines. ...
http://www.bioportfolio.com/cgi-bin/acatalog/Competitor-Anal...
|
BioPortfolio - Oxagen Limited
Oxagen is focused on becoming a significant biopharmaceutical company, developing a ... production by Th2 lymphocytes in response to activated mast
cells. ...
http://www.bioportfolio.com/biocorporate/7961-Oxagen+Limited...
|
BioPortfolio - Keel Pharmaceuticals, Inc.
Keel Pharmaceuticals, Inc. is a private biopharmaceutical company that is ... of auto reactive lymphocytes and re-establishment of immune tolerance. ...
http://www.bioportfolio.com/biocorporate/25222-Keel_Pharmace...
|
BioPortfolio - the biotechnology, pharmaceutical, life science and ...
BioCorporate - 27000 company profiles with description, contact, location map, ... publications, patents, clinical trials, news eg Sarcoma, Lymphocytes ...
http://www.bioportfolio.com/bookshop/search/Odontodysplasia/...
| Results from other life science and pharmaceutical sites:
Increased frequency of antigen-specific CD8+ cytotoxic T ...
The mAb's were purchased from the following companies: CD3, CD4, CD56, ... Preparation of LCLs, an EBV-specific CTL line, and PBMCs activated by PHA and IL
-2. .... For determination of CD8+ antigen-specific T-lymphocyte frequency, ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC408473/...
|
Immunotherapy of Metastic Renal Cell Cancer: Exogenous Lymphocyte ...
Exogenous Lymphocyte Infusion: Renal cancer accounts for about 3% of all solid tumors ... Variations in the preparation of TILs or the preparation of the host
..... relationship exists between the authors and the companies/organizations
...
http://www.medscape.com/viewarticle/442386_12...
|
Potassium channels in T lymphocytes: therapeutic targets for ...
Human peripheral blood T lymphocytes possess two types of K(+) channels: the ... in academia and pharmaceutical companies to characterize the expression of ...
http://www.ncbi.nlm.nih.gov/pubmed/15377175...
|
BioMed Central | Full text | Total blood lymphocyte counts in ...
The correlations of total blood lymphocyte counts with sex, age, ..... a group of professional societies and diagnostic companies on guidelines for interim ...
http://www.biomedcentral.com/1471-2326/5/5...
|
DNA damage in T- and B-lymphocytes and granulocytes in emission ...
Twenty-four workers from three automobile emission inspection companies, ... In T-lymphocytes, DNA damage in control subjects, emission inspection workers ...
http://www.ncbi.nlm.nih.gov/pubmed/12834760...
|
Diseases of Large Granular Lymphocytes: Aggressive NK-Cell Leukemia
Characterization of T-cell large granular lymphocyte leukemia associated .... No significant relationship exists between the authors and the companies/
organizations ... Leukaemia: Preparation is Everything · Rituximab-Induced
Changes in ...
http://www.medscape.com/viewarticle/556140_5...
|
Occupational Toluene Exposure Induces Cytochrome P450 2E1 mRNA ...
Preparation of standard RNA. A set of primers was designed based on the human CYP2E1 ..... study of workers from 25 Mexican companies (52.5–931 ppm) in which
the workers ..... Human lymphocytes cytochrome P450 2E1, a putative marker for
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1440770/...
|
Diseases of Large Granular Lymphocytes: Conclusions
Sokol L, Loughran TP Jr. Large granular lymphocyte leukemia. ..... No significant relationship exists between the authors and the companies/
organizations whose ... Leukaemia: Preparation is Everything · Rituximab-Induced
Changes in ...
http://www.medscape.com/viewarticle/556140_6...
|
The paracaspase MALT1 controls caspase-8 activation during ...
Human and mouse lymphocytes defective in caspase-8 show profound defects in ..... IL-7 (PHC-0074) (Invitrogen) were purchased from the indicated companies.
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2690087/...
|
GFS, a preparation of Tasmanian Undaria pinnatifida is associated ...
We sought to assess whether GFS, a proprietary preparation of Tasmanian Undaria ... is of interest to patients and to drug companies investigating more
effective remedies. ..... activity of seaweed extract on human lymphocytes in
vitro. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=13...
|
|
